HIM
CC icon

Hillsdale Investment Management’s Chemours CC Stock Holding History

Hillsdale Investment Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,310
Closed -$234K – 604
2018
Q4 		$234K Sell
8,310
-500
-6% -$15.8K 0.03% 388
2018
Q3 		$348K Hold
8,810
– – 0.05% 247
2018
Q2 		$390K Buy
8,810
+7,560
+605% +$376K 0.05% 242
2018
Q1 		$61K Sell
1,250
-7,500
-86% -$375K 0.01% 301
2017
Q4 		$438K Hold
8,750
– – 0.07% 220
2017
Q3 		$443K Buy
8,750
+8,570
+4,761% +$404K 0.07% 200
2017
Q2 		$7K Sell
180
-28,020
-99% -$1.11M ﹤0.01% 357
2017
Q1 		$1.09M Buy
+28,200
New +$849K 0.22% 91

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Hillsdale Investment Management's CC Position: Q1 2019 in Review

Hillsdale Investment Management sold out of Chemours (CC) in Q1 2019, closing a stake of 8,310 shares — an estimated $234K sold.

Hillsdale Investment Management first reported a position in CC in Q1 2017 and held it in 8 quarters. The position peaked at $1.09M in Q1 2017. 540 funds tracked by Wall St. Rank hold CC as of Q1 2019.

  • Hillsdale Investment Management reported no remaining Chemours position as of Q1 2019 after selling out during the quarter.
  • Hillsdale Investment Management sold 8,310 Chemours shares in Q1 2019, an estimated $234K.
  • Hillsdale Investment Management first reported a position in Chemours in Q1 2017 and held it in 8 quarters.
  • Hillsdale Investment Management's Chemours position peaked at $1.09M in Q1 2017.
  • 540 funds tracked by Wall St. Rank held Chemours as of Q1 2019.

Based on Hillsdale Investment Management's 13F filing for Q1 2019, filed 13 May 2019.